Adverse COVID-19 outcomes in American Veterans with age-related macular degeneration: a case-control study.

ABSTRACT:

Objectives

Prior studies suggest that patients with age-related macular degeneration (AMD) have poorer COVID-19 outcomes. This study aims to evaluate whether AMD is associated with adverse COVID-19 outcomes in a large clinical database.

Design

Case-control study.

Setting

We obtained demographic and clinical data from a national US Veterans Affairs (VA) database for all Veterans aged 50 years or older with positive COVID-19 testing prior to 2 May 2021.

Primary and secondary outcome measures

The primary outcome measure was hospitalisation. Secondary outcome measures were intensive care unit admission, mechanical ventilation and death. Potential associations between AMD and outcome measures occurring within 60 days of COVID-19 diagnosis were evaluated using multip

SUBMITTER: Armbrust KR 

PROVIDER: S-EPMC10748956 | biostudies-literature | 2023 Dec

REPOSITORIES: biostudies-literature